Showing 21,381 - 21,400 results of 34,782 for search '(( 50 ((a decrease) OR (mean decrease)) ) OR ( 5 ((point decrease) OR (nn decrease)) ))', query time: 1.00s Refine Results
  1. 21381

    The effects of purmorphamine and Msi1 knockdown on p21<sup>CIP1,WAF1</sup> and c-Myc expression. by In-Sun Hong (284033)

    Published 2013
    “…Purmorphamine treatment decreased and increased the expression of p21<sup>CIP1,WAF1</sup> (<b>A</b>) and c-Myc (<b>B</b>), respectively. …”
  2. 21382

    Image 3_Hydrogel and scalp/skin conductivities impact dose from tumor treating fields.png by Edwin Lok (3512405)

    Published 2025
    “…Although scalp hotspots increased or decreased by +1.5%, −0.1%, and −0.9% in E<sub>5%</sub>, SAR<sub>5%</sub>, and CD<sub>5%</sub>, the skin hotspots increased by as much as +23.5%, +45.7%, and +20.6%, respectively. …”
  3. 21383

    Image 2_Hydrogel and scalp/skin conductivities impact dose from tumor treating fields.png by Edwin Lok (3512405)

    Published 2025
    “…Although scalp hotspots increased or decreased by +1.5%, −0.1%, and −0.9% in E<sub>5%</sub>, SAR<sub>5%</sub>, and CD<sub>5%</sub>, the skin hotspots increased by as much as +23.5%, +45.7%, and +20.6%, respectively. …”
  4. 21384

    Image 1_Hydrogel and scalp/skin conductivities impact dose from tumor treating fields.png by Edwin Lok (3512405)

    Published 2025
    “…Although scalp hotspots increased or decreased by +1.5%, −0.1%, and −0.9% in E<sub>5%</sub>, SAR<sub>5%</sub>, and CD<sub>5%</sub>, the skin hotspots increased by as much as +23.5%, +45.7%, and +20.6%, respectively. …”
  5. 21385
  6. 21386
  7. 21387
  8. 21388
  9. 21389
  10. 21390
  11. 21391
  12. 21392
  13. 21393

    Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain by Qiru Wang (12260453)

    Published 2024
    “…</p> <p>In experiments conducted on neuropathic rats, both systemic and intrathecal administration of astilbin, an essential constituent, exhibited a noteworthy and dose-dependently decrease in chronic and acute pain behaviours. …”
  14. 21394
  15. 21395

    Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts by Li Liu (75607)

    Published 2012
    “…The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging. A single dose of BPR0L075 (50 mg/kg, intraperitoneally (i.p.)) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 hours); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate. …”
  16. 21396
  17. 21397
  18. 21398
  19. 21399
  20. 21400